Startups CVS Health Stock Gains Shape Australian Startups similispharma@gmail.comApril 6, 20260 If you’d invested $100 in CVS Health (CVS) stock five years ago, you’d be surprised to know that you wouldn’t…
Startups Investors Rotate Out of Palantir in Australia Startups similispharma@gmail.comApril 5, 20260 As investors in Australia’s startup ecosystem continue to navigate the challenging market conditions, a major shift is underway. A prominent…
Startups Australia Startups Boosted By Better Home Finance similispharma@gmail.comApril 5, 20260 The Australian startup scene is abuzz with excitement as Better Home & Finance Holding, a leading player in the burgeoning…
Startups Australia Startups Boom With 3 High Yield Stocks similispharma@gmail.comApril 4, 20260 Australian investors are constantly on the lookout for opportunities to grow their wealth, and investing in high-yield stocks is a…
Startups Rigetti Computing Leads Australia Startups similispharma@gmail.comApril 4, 20260 As the Australian startup ecosystem continues to thrive, a new wave of innovation is emerging that could revolutionise the way…
Startups Australia Startups Harbor Commodity ETF HGER Outpaces Rivals similispharma@gmail.comApril 3, 20260 As the Australian economy continues to navigate the complexities of global market fluctuations, a standout performer in the commodity space…
Startups Startups in Australia See Nat Gas Prices Drop similispharma@gmail.comApril 3, 20260 The weekly storage build report is out, and it’s sending shockwaves through the Australian energy markets. For the first time…
Startups Australia Startups Thrive Amid Bitcoin Stress similispharma@gmail.comApril 2, 20260 As the global financial landscape continues to shift, one development is casting a spotlight on the resilience of a particular…
Startups Meta Surges 4% in Australia Startups similispharma@gmail.comApril 2, 20260 Meta Platforms has given investors a reason to buy the dip, surging 4% in recent trading sessions as the tech…
Startups Fidelity ETF Down 12% in Australia Startups similispharma@gmail.comApril 1, 20260 In a significant development that’s sending shockwaves through Australia’s startup ecosystem, the Fidelity Disruptive Technology ETF has taken a 12%…